To systematically characterize the clinical features of headache attributed to anxiety and depressive disorders (HA-ADD) for better recognition and management, emphasizing the importance of early diagnosis.
Key Findings:
Predominantly female cohort (70.3%) with a median age of 36 years.
Common locations: temporal (47.5%) and parietal (35.6%).
60.4% of attacks lasted less than 4 hours.
Associated symptoms included phonophobia (79.2%), restlessness/agitation (58.4%), dizziness (57.4%), and nausea (51.5%).
Emotional fluctuations (71.3%) and poor sleep quality (57.4%) were predominant triggers.
73.2% of patients experienced severe headache-related functional impairment (HIT-6 score >60).
Exclusion criteria included a history of any diagnosis meeting the ICHD-3 criteria for primary headache disorders.
Interpretation:
HA-ADD presents a distinct clinical profile that differentiates it from common primary headache disorders, highlighting the need for specific diagnostic and therapeutic approaches, which could improve patient outcomes.
Limitations:
Study conducted at a single center, limiting generalizability.
Reliance on patient recall for headache and mood symptom correlation may introduce bias, potentially affecting the accuracy of findings.
Conclusion:
The study provides a detailed characterization of HA-ADD, which may facilitate earlier diagnosis and appropriate treatment interventions, underscoring the need for further research in this area.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
